Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The stage is set for revolutionary advances in medicine and biotechnology it is claimed, following substantial investment in cryo-electron microscopy in Oxford awarded by the Wellcome Trust in its April 2016 funding round.

The Collaborative Award in Science, headed by the Dunn School's Susan Lea, has been made to a cross - departmental team. 

Professor Lea said:  “The cell is the fundamental unit of all life and there is an impending transformation in our understanding of how it functions. This will set the stage for a step-change in medicine and biotechnology, as well as being likely to found whole new industries – by analogy to the molecular biology revolution of the 20th century. These exciting changes are being catalysed by many advances, but the most direct technological revolution has been in cryo-electron microscopy.”

Read more (Sir William Dunn School of Pathology website)

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.